摘要
目的：探究氟西汀治疗卒中后抑郁疗效观察。方法：对照组基础治疗下给予心理治疗，观察组在此基础上给予氟西汀治疗，观察对比临床疗效。结果：治疗2个月后，观察组临床总有效率为91.67%，明显高于对照组的66.67%；观察组治疗后的的HAMD和SDS，明显低于对照组；治疗后6～12个月随访，观察组抑郁发病率10.42%，明显低于对照组的43.7%，组间比较差异具有统计学意义，P＜0.05。且观察组用药无明显药物不良反应。结论：氟西汀治疗卒中后抑郁疗效确切，可改善患者心理情绪和精神状态，且用药安全，值得临床应用和推广。
To explore the efficacy of fluoxetine on stroke depression. Methods: patients in the control group were given psychotherapy, while patients in the treatment group were given fluoxetine and the efficacy was observed. Results: After 2 months of treatment, the total effective rate of the observation group was 91.67%, significantly higher than that of the control group 66.67%; after treatment, HAMD and SDS of the observation group were significantly lower than those of the control group; After treatment for 6 to 12 months of follow-up, the incidence of depression in the observation group was 10.42%, significantly lower than that of the control group 43.7% , the differences between groups were statistically significant, P<0.05. The observation group had significant adverse reactions . Conclusion: Fluoxetine has an accurate effect on stroke depression and improve the psychological emotion and mental states safely, which is worthy of clinical application and promotion.
出处
《中医临床研究》
2014年第21期60-61,共2页
Clinical Journal Of Chinese Medicine
关键词
氟西汀
脑卒中
抑郁
Fluoxetine
Stroke
Depression
